Monday back up ?

“Mesyuarat dipengerusikan bersama oleh YB Dato' Sri Dr Adham Baba , Menteri Kesihatan Malaysia dan YB Khairy Jamaluddin, Menteri Sains dan Inovasi. Antara lain mesyuarat membincangkan jaminan akses vaksin Covid-19 untuk diperolehi oleh rakyat Malaysia.

Bersama-samalah kita mendoakan agar vaksin yang benar-benar berkualiti, teruji dan selamat dapat diakses oleh seluruh rakyat Malaysia nanti.”

Translation :
The meeting was co-chaired by YB Dato 'Sri Dr Adham Baba, Minister of Health Malaysia and YB Khairy Jamaluddin, Minister of Science and Innovation. Among other things, the meeting discussed the guarantee of access to the Covid-19 vaccine for Malaysians to obtain.

Together we pray that a truly quality, tested and safe vaccine can be accessed by all Malaysians later.

https://www.facebook.com/373560576236/posts/10157455912156237/?extid=0&d=n

Pity those who panic sell. Based on insider info : There will be no announcement tonight from incumbent PM until Agong decides in consultation with the rulers. So we will have to wait and see. Hope Agong makes the right decision.

"Nothing tonight. Confirmed," said the said the source https://www.facebook.com/TheStarOnline/posts/10156951564572255

If Biden wins the election, will oil price drop? I saw the debate, he is pro renewable energy and anti oil and gas
https://edition.cnn.com/2020/10/22/politics/cnn-poll-final-presidential-debate/index.html

@Noobie123 Agreed. Me too.

So far vaccine together with preventive measures such as safe distancing and facial masks are the way to go as currently there are no safe and effective treatment / cure for covid Infections.

U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns

https://www.google.com/amp/s/www.cnbc.com/amp/2020/10/13/us-pauses-eli-lillys-trial-of-a-coronavirus-antibody-treatment-over-safety-concerns.html

Remdesivir, Hydroxychloroquine found not effective in Covid-19 treatment

https://www.theedgemarkets.com/article/remdesivir-hydroxychloroquine-found-not-effective-covid19-treatment

Conclusion is Inactivated vaccines have the edge over mRNA vaccines and adenovirus vector vaccines

Congrats to those still holding. Too bad I already left quite some time ago for prlexus. No patience. This company has solid fundamentals and will continue to grow.

mRNA vaccine is not practical/ feasible to be widely used in Malaysia, especially in the rural areas

"mRNA is an incredibly unstable molecule. In fact it can degrade itself if exposed to even a little bit of heat or base and for that reason has to be stored at- 80 °C (which is why NO MRNA VACCINE CANDIDATE IS LIKELY GOING TO BE THE FIX FOR COVID-19 IN LOWER AND MIDDLE INCOME NATIONS)."

https://medium.com/@edwardnirenberg/mrna-vaccines-and-covid-19-3ee8590617c5

China is in talks to have its locally-produced COVID-19 vaccines assessed by the World Health Organization, as a step toward making them available for international use

https://www.livemint.com/news/world/china-in-talks-with-who-over-assessing-its-covid-19-vaccines-for-global-use-11601974876196.html

Sinopharm, the largest healthcare company in China...

As the world's largest JE vaccine provider, Sinopharm accounts for 80 percent of global JE vaccine consumption...

http://global.chinadaily.com.cn/a/201907/01/WS5d196381a3103dbf1432b216.html

https://www.bernama.com/en/general/news_covid-19.php?id=1869845

China-based SINOPHARM has commenced a Phase III clinical trial of its Covid-19 vaccine candidate at the Bahrain International Exhibition and Convention Centre (BIECC).

The trial received approval from the National Health Regulatory Authority (NHRA).

During the study in Bahrain, Sinopharm’s inactivated vaccine candidate will be assessed for its effectiveness in antibody generation and the acquired protection against the virus.

THE VACCINE CANDIDATE IS PRE-QUALIFIED BY THE WORLD HEALTH ORGANIZATION AND PARTICIPANTS CAN REGISTER VIA THE NATIONAL VOLUNTEER PLATFORM.

https://www.clinicaltrialsarena.com/news/bahrain-vaccine-trial-sinopharm/

Honestly i dont see any downside in investing in Kangar now that we know more about Sinopharm Vaccines.

This gives me the confidence that Sinopharm's covid vaccine will have NO PROBLEMS AT ALL obtaining WHO prequalification approval

" Vaccine “Made in China” and prequalified by WHO for the first time become available for UN procurement

Oct 9th, 2013, the World Health Organization (WHO) officially announced in Geneva: the live attenuated Japanese Encephalitis vaccine (SA14-14-2) (Hereinafter as “JE live vaccine”) produced by Chengdu Institute of Biological Products Co., Ltd., a subsidiary of China National Biotec Group Company Limited, a SINOPHARM GROUP COMPANY, HAS OBTAINED WHO PRE-QUALIFICATION. This is the first time that a vaccine made in China has passed WHO PQ, and become a new source for UN procurement agencies. This marks a new milestone of China’s vaccine industry."

http://www.sinopharm.com/en/s/1395-4689-27983.html

Old news but this shows SInopharm has the capacity to produce vaccines which meet World Health Organization (WHO) prequalification standards.This strengthens the possibility that Sinopharm Covid Vaccine will be able to obtain WHO prequalification which meets international standards and can be exported all over the word.

"When WHO pre-qualified a Chinese-made vaccine for the first time last October, the move showed what Chinese vaccine manufacturers could potentially achieve and – in a sense – paved the way for others to follow suit.

“The prequalification of the Japanese encephalitis vaccine in China is a big step forward, and now several other Chinese producers are interested in obtaining prequalification for their vaccines,” says Melissa Malhame, whose team at the GAVI Secretariat in Geneva works with vaccine manufacturers around the world to ensure sufficient supply of high quality vaccines at affordable prices.

This and other Chinese vaccines are licensed by the China Food and Drug Administration (CFDA) that is part of China’s National Regulatory Authority (CNRA), which received WHO’s seal of approval in March 2011, after finding that it met WHO standards for vaccine regulatory oversight.

In July, this status was renewed, after a successful WHO reassessment of the vaccine regulatory part of the CNRA. WHO Director-General Dr Margaret Chan welcomed the news saying: “As a result of this evaluation, WHO is confident in the quality, safety and effectiveness of vaccines that are made in China.”

THE DOMINANT PLAYER IN CHINA’S VACCINE INDUSTRY IS STATE-OWNED SINOPHARM’S SUBSIDIARY CHINA NATIONAL BIOTECHNOLOGY GROUP, COMPRISING SEVEN MANUFACTURERS – ONE OF WHICH IS THE CHENGDU INSTITUTE OF BIOLOGICAL PRODUCTS, THE PRODUCER OF THE JAPANESE ENCEPHALITIS VACCINE THAT WAS PREQUALIFIED LAST YEAR."

https://www.who.int/bulletin/volumes/92/9/14-020914/en/

Pfizer's vaccine needs to be stored at negative 94 degrees Fahrenheit, executives previously said, according to MarketWatch. Another mRNA shot from Moderna requires storage at negative 4 degrees Fahrenheit.

The requirements would make standard vaccination in a doctors' office or pharmacy "very difficult," SVB Leerink analysts wrote. The vaccinations would instead have to take place at hospitals, labs or other under circumstances, they said.

https://www.fiercepharma.com/manufacturing/pfizer-designed-new-container-and-plans-to-tap-shipping-companies-for-covid-19

There is no COVID-19 vaccine being developed specifically for children. So if children are to be vaccinated, they will likely receive the same vaccine as adults. They might require a different dosing schedule, but that is not yet clear.

https://theconversation.com/children-may-need-to-be-vaccinated-against-covid-19-too-heres-what-we-need-to-consider-146404

Complicated stuff but this is a real concern for other ongoing clinical trials of covid vaccine which are lagging behind and can potentially disrupt the retention rate of participants in those clinical trials once the first covid vaccine in the world has been approved. This is because once the first covid vaccine in the world has been approved, some of the participants from the other ongoing clinical trials may demand to know whether they are being given the placebo or the actual vaccine. Once they find out, those on the placebo might opt to drop out of the clinical trial to get themselves vaccinated with the first covid vaccine in the world that has been approved. It may or may no longer be ethically possible or feasible to continue the clinical trials. Currently that is not a concern with Sinopharm Covid Vaccine as they are currently leading the global vaccine race.

https://www.malaymail.com/news/life/2020/10/23/placebo-group-what-happens-after-a-covid-vaccine-is-authorised/1915471

US stocks erase early losses as stimulus talks continue

https://www.google.com/amp/s/amp.ft.com/content/13766670-75b6-4d74-9bed-68b0bb1e0553

Disadvantages of adenovirus vector vaccine and mrna vaccine. Best to stick to tried and tested vaccine technology ie inactivated vaccines eg Sinopharm vaccine

“Viral vector vaccine
This approach isn't new — it dates back to the 1980s — but only one viral vector vaccine has been ever been licensed for human use: Sanofi's Dengue vaccine.

Though the technology has shown promise, the two leading developers of coronavirus vector vaccines — AstraZeneca and Johnson & Johnson — have both put their US trials on hold to investigate unexplained illnesses in participants.

The vector approach may pose challenges for booster shots, though, since the body may recognize the adenovirus and attack it right away.


mRNA vaccine: the new kid on the block
No vaccine using this technology has ever been approved for human use.

there are challenges when delivering and storing them: Pfizer's vaccine needs to be shipped at -94 degrees Fahrenheit and Moderna's at -4 degrees Fahrenheit. In Pfizer's case, that would require vaccination sites to have deep freezers or dry ice on hand


The coronavirus mutates far more slowly than the flu, so researchers think a vaccine will remain effective over a longer time.

https://www.google.com/amp/s/www.businessinsider.com/leading-us-coronavirus-vaccines-how-they-work-compare-2020-10%3famp

Risk Associated with adenovirus vector vaccine

https://www.google.com/amp/s/amp.scmp.com/news/china/diplomacy/article/3106697/scientists-say-some-covid-19-vaccines-under-trial-need

Health Minister Hala Zayed headed on Monday to Egypt’s Holding Company for Biological Products and Vaccines (VACSERA) to take the second shot of the candidate coronavirus vaccine developed by the Chinese company Sinopharm.

https://www.egypttoday.com/Article/1/93310/Egyptian-health-minister-gets-2nd-shot-of-candidate-coronavirus-vaccine

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics

The programme has stalled ahead of phase 3 testing however, as other candidates from AstraZeneca/Oxford University, Moderna and Pfizer/BioNTech – as well as Chinese rivals Sinopharma and Sinovac Biotech – have forged ahead.

https://pharmaphorum.com/news/losing-ground-in-covid-19-vaccine-race-cansino-turns-to-russia/

Scientists outside the company have expressed concern that the effectiveness of CanSino's candidate Ad5-nCoV, which is based on a common cold virus to which many people have been exposed, could be limited. They said existing antibodies against the common cold virus might undermine Ad5-nCoV.

AstraZeneca Plc on Tuesday said it paused a late-stage trial of one of its leading experimental viral vector-based vaccine, which uses a technology similar to CanSino's, after an unexplained illness in a study participant.

https://www.theedgemarkets.com/article/chinas-cansino-defends-coronavirus-vaccine-candidate-after-experts-cast-doubt

https://www.sciencemag.org/news/2020/10/could-certain-covid-19-vaccines-leave-people-more-vulnerable-aids-virus

Sinopharm/SInovac Vaccine is safer than CanSIno vaccine and possibly more effective.

"Why China's bet on 'analogue' Covid-19 vaccines could pay off

Three of the four Chinese vaccine candidates [referring to Sinovac and Sinopharm vaccine ] in the final stage of clinical trials are inactivated vaccines a simple technique that kills off the Sars-CoV-2 virus in a lab and uses it to trigger an immune response.

But this strategy appears to be playing out well. Not only have the Chinese vaccines been among the fastest to reach phase 3 trials, data from the earlier phases showed positive results after all three inactivated vaccines induced antibodies and T-cell responses.

So far they have also shown milder side effects compared to other technologies.

A fourth Chinese candidate developed by military scientist Chen Wei and CanSino, which uses a weakened cold virus as a vector, HAS MORE SIDE EFFECTS AND MAY BE LESS EFFECTIVE BECAUSE MANY PEOPLE ALREADY HAVE IMMUNITY TO THE VIRUS USED."

Original link has paywall :
https://www.scmp.com/news/china/science/article/3103531/why-chinas-bet-analogue-covid-19-vaccines-could-pay

Alternate link :
https://webcache.googleusercontent.com/search?q=cache:dABCBbuofzwJ:https://lotgain.com/why-chinas-bet-on-analogue-covid-19-vaccines-could-pay-off%25E4%25B8%25BA%25E4%25BB%2580%25E4%25B9%2588%25E4%25B8%25AD%25E5%259B%25BD%25E6%258A%25BC%25E6%25B3%25A8%25E6%25A8%25A1%25E6%258B%259F%25E7%2596%25AB%25E8%258B%2597covid-19%25E7%2596%25AB/+&cd=7&hl=en&ct=clnk&gl=my

CanSino has agreed to provide 100,000 single-dose vaccines for Indonesia in November and expects to deliver between 15 million and 20 million doses in 2021. Sinopharm, meanwhile, is expected to deliver 15 million dual-dose vaccines this year, with 5 million expected to be delivered in November. Sinovac has pledged to ship 3 million doses until the end of this year, with 1.5 million single-dose vials to be delivered in the first week of November.

https://www.thejakartapost.com/paper/2020/10/12/ri-can-be-manufacturing-hub-for-covid-19-vaccine-chinese-foreign-minister.html

Food for thought

https://www.tradingview.com/chart/KANGER/uylt9g30-Arah-tuju-KANGER/

Technical stuff - Published preliminary results on Sinopharm vaccine

https://jamanetwork.com/journals/jama/fullarticle/2769612

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32137-1/fulltext
22/10/2020 7:22 PM

I am of the opinion that Kanger is the most promising vaccine related counter - even more so than Solution, HWGB, Bintai and maybe even DPharma or Pharma. As to why, I will back all these up with facts once i have the time but in summary, Sinopharm vaccine as well as Sinovac Vaccine (both inactivated vaccines from China) are currently leading the global vaccine race even further ahead of USA and UK vaccines and are hence the most likely and promising covid vaccines to be the first world wide to obtain regulatory approval, not to mention Sinopharm vaccine ceritified Halal in UAE. Furthermore with coming signing of the Covid-19 MoU between China and Malaysia, the inking of exclusive distribution agreement with Sinopharm as well as China's assurance that Malaysia will be give priority access to their vaccines, these no doubt further strengthens the position of Kanger as the most promising vaccine related counter in Bursa.

@staload My personal opinion on the TP is RM 3. It might even overtake Carepls. This question regarding TP is very subjective so take it with a pinch of salt.

@Passivereturn Lol i am just simply sharing the good news based on facts and not on hear say. So it is up to you to make your own informed decision whether or not to join.

China has not set any conditions for prioritizing the Philippines for the supply of coronavirus vaccines being developed in the mainland, Philippine Ambassador to Beijing Chito Sta. Romana said on Thursday.

"The prospects are bright in terms of a breakthrough in a vaccine," he added, noting that one or two brands are likely to be approved soon.

Pharmaceutical firms Sinovac and Sinopharm are close to completing phase 3 trials, the last step before regulatory approvals are given for widespread inoculation of vaccine doses, Sta. Romana noted.

The ambassador, however, said some 60,000 Chinese nationals have received the vaccines, including health workers and port frontliners who agreed as volunteer subjects.

"There been no report of an adverse reaction," he noted.

https://www.cnnphilippines.com/news/2020/10/22/no-conditions-China-vaccine-access.html

Need to monitor all stocks closely until USA election is over. Cut loss if necessary.

As long as it stays at or above the support level of 185 should be fine for now compared to other glove and pharma counters which are red at the moment.

Today stock market overall very bad...

this stock has lost power

This stock has lost power.

Acceptance rates again varied widely by country, with China again having the most clearly positive responses (84 per cent either completely or somewhat agreed) and Russia with the least (27 per cent).

https://www.malaymail.com/news/world/2020/10/20/scientists-raise-alarm-over-signs-of-vaccine-hesitancy/1914660

It is understood that Beijing has gone for the traditional attenuated vaccines developed by SinoPharm as a safer bet. The use of another type, an adenovirus vector vaccine developed by the People’s Liberation Army’s Military Science Academy, would be initially limited to PLA personnel.

https://asiatimes.com/2020/10/beijing-ramps-up-vaccine-diplomacy-for-neighbors/

Prior to their trip to Britain, Ms Retno and Mr Erick embarked on a similar mission to China in August to secure massive supplies of potential Covid-19 vaccines from several Chinese vaccine producers, including Sinovac and Sinopharm, setting up a future stockpile of nearly 300 million doses until the end of next year.

https://www.straitstimes.com/asia/se-asia/indonesia-secures-deal-to-procure-100m-more-doses-of-vaccines-from-astrazeneca

At the invitation of China's African Affairs Department of the Ministry of Foreign Affairs, 51 African envoys and senior diplomats on Oct 16 paid a visit to Sinopharm, one of the world's leading human vaccine research, development and manufacturing enterprises.

"China is ready to strengthen vaccine cooperation with African countries on the basis of fully respecting Africa's will. We are prepared to provide vaccines to African countries as a matter of priority," Wu said. "China's position is clear, vaccine development is a matter of human health. We call on the international community to come together in solidarity with respect for science and life

While addressing the delegation Liu Jingzhen, chairman of the Sinopharm Group, outlaid the outstanding achievements of Sinopharm in COVID-19 drug manufacturing, medical treatment and vaccine research and development. He also said that Sinopharm stands ready to further strengthen COVID-19 vaccine and other aspects of cooperation with African countries to jointly defeat the virus.

Sinopharm is currently carrying out international phase three clinical trials for a COVID-19 vaccine in ten countries, including the United Arab Emirates, Peru and Argentina. More than 50,000 volunteers are taking part in these trials according to the company.

http://www.ecns.cn/news/politics/2020-10-20/detail-ihaazqys6710309.shtml

Coronavirus: UAE minister Sheikh Saif bin Zayed gets Covid-19 vaccine

In recent weeks, several ministers have received the vaccine.

Last month, the UAE granted approval for the emergency use of the Covid-19 vaccine that is being trialled in the country. The vaccine, developed by China's Sinopharm, is now in the third and final stage of clinical trials and has so far been found safe and effective, according to authorities.

Over 31,000 volunteers had received the jab as part of the program. The vaccine is being administered to frontline workers and professionals who are at highest risk of contracting the virus. A number of top officials have also taken it.

Other UAE ministers who have taken the Covid-19 vaccine include Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation; Abdulrahman Al Owais, Minister of Health and Prevention; Obaid Al Shamsi, director general of the National Emergency Crisis and Disasters Management Authority; Noura Al Kaabi, UAE Minister of Culture and Youth, Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Member of the Executive Council and Chairman of the Abu Dhabi Executive Office was administered the vaccine on September 24.

https://www.khaleejtimes.com/coronavirus-pandemic/coronavirus-uae-royal-minister-sheikh-saif-gets-covid-19-vaccine-

The World Health Organization (WHO) and Vaccine Alliance (GAVI), two global leading facilitators in promoting COVID-19 vaccine equal distribution around the world, recently applauded China's efforts to support vaccine accessibility to some underdeveloped countries, hailing China's decision to join the COVID-19 Vaccines Global Access Facility, or COVAX, which the US has spurned.

"It is very positive news that China has become part of the COVAX Facility, as it gives even more momentum to our efforts to ensure global, equitable access to COVID-19 vaccines. The COVAX Facility now has 182 economies involved and vaccine deals are underway," a spokesperson for GAVI, which co-initiated COVAX, told the Global Times in a recent interview via text.

China officially joined COVAX on October 8, which is seen as an essential to upholding the concept of a shared community of health for all and to honor its commitment to turn potential COVID-19 vaccines into a global public good.

Butantan Institute reported that 35 percent of the 9,000 Coronavac volunteers in the late-stage clinical trials in Brazil had only mild reactions, such as pain at the application site, and no serious side effects, according to the statement the Institute sent to the Global Times on Tuesday.

https://www.globaltimes.cn/content/1204275.shtml

China promises to sell Covid-19 vaccines at ‘fair and reasonable’ price around the world

China has promised that its Covid-19 vaccines will be sold around the world at a “fair and reasonable” price, with help available for developing countries.

“For underdeveloped or developing countries, we will provide assistance to those countries to help achieve accessibility and affordability of Covid-19 vaccines.”

Zheng said that companies had the right to set their own prices, but should consider setting a price based on manufacturing cost rather than market forces.

President Xi Jinping has repeatedly said that Chinese-made vaccines will be a “global public good” without explaining what this means.

But Zheng’s comments suggest this means they will be on sale globally, with financial help on offer to countries that would otherwise struggle to pay for them.

https://sg.news.yahoo.com/china-promises-sell-covid-19-113842553.html

@starload what announcement are you referring to?

@BigPortfolio Everyone has different risk appetite. There is no one size fit all way of trading/ investing in the stock market. So i say to each his own.

@Liverfool Agreed. *Hint *Hint @BigPortfolio

@BigPortfolio There is no news stating that covid vacine caused any deaths in China and Korea. The case regarding the deaths in korea is related to the FLU VACCINE, and not Covid Vaccine. The death in Brazil is not even linked to the vaccine as the volunteer was given a PLACEBO and not the actual vaccine itself. Furthermore, the trial in Brazil is Astrazeneca trial comparing the efficacy of placebo versus ADENOVIRUS VECTOR VACCINE and NOT inactivated vaccine which is what Sinopharm and Sinovac from China are based on. OMG please do not invest in this stock if you do not even know the facts. Get your facts right !

Let us all pray for the best